Progression of female reproductive stages associated with bipolar illness exacerbation
Version of Record online: 31 MAY 2012
© 2012 John Wiley and Sons A/S
Volume 14, Issue 5, pages 515–526, August 2012
How to Cite
Marsh, W. K., Ketter, T. A., Crawford, S. L., Johnson, J. V., Kroll-Desrosiers, A. R. and Rothschild, A. J. (2012), Progression of female reproductive stages associated with bipolar illness exacerbation. Bipolar Disorders, 14: 515–526. doi: 10.1111/j.1399-5618.2012.01026.x
- Issue online: 26 JUL 2012
- Version of Record online: 31 MAY 2012
- Received 26 May 2011, revised and accepted for publication 16 April 2012
- bipolar disorder;
- mood disorders;
Marsh WK, Ketter TA, Crawford SL, Johnson JV, Kroll-Desrosiers AR, Rothschild AJ. Progression of female reproductive stages associated with bipolar illness exacerbation. Bipolar Disord 2012: 14: 515–526. © 2012 The Authors. Journal compilation © 2012 John Wiley & Sons A/S.
Objectives: Late perimenopause and early postmenopause confer an increased risk of depression in the population, yet bipolar disorder mood course during these times remains unclear.
Methods: Clinic visits in 519 premenopausal, 116 perimenopausal (including 13 women transitioning from perimenopause to postmenopause), and 133 postmenopausal women with bipolar disorder who received naturalistic treatment in the multisite Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study over 19.8 ± 15.5 months were analyzed for mood state. History of postpartum and perimenstrual mood exacerbation and current hormone therapy were evaluated as potential mood predictors.
Results: A progression in female reproductive stage (premenopause, perimenopause, and postmenopause) was significantly associated with percent of visits decreasing in euthymia (29.3%, 27.0%, 25.0%, respectively, p < 0.05), decreasing in syndromal mood elevation (5.3%, 4.1%, and 3.0%, respectively, p < 0.001), and increasing in subsyndromal symptoms (47.3%, 50.7%, and 52.7%, respectively, p = 0.05). Thirteen women transitioning from peri- to postmenopause had a significantly greater proportion of visits in syndromal depression (24.4%, p < 0.0005) compared to premenopausal, perimenopausal, and postmenopausal women, while depression in the latter three groups (18.1%, 18.1%, and 19.3%, respectively) did not differ. Perimenstrual and/or postpartum mood exacerbation, or hormone therapy did not significantly alter depression during perimenopause.
Conclusions: A progression in female reproductive stages was associated with bipolar illness exacerbation. A small number of women transitioning from perimenopause to postmenopause had significantly greater depression than other female reproductive groups. Euthymia and mood elevation decreased with progressing female reproductive stage. Menstrual cycle or postpartum mood exacerbation, or current hormone therapy use, was not associated with perimenopausal depression. Future studies, which include hormonal assessments, are needed to confirm these preliminary findings.